Single-use Bioprocessing Pump Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

Single-use Bioprocessing Pumps Market Overview

The Single-use Bioprocessing Pumps market is experiencing significant growth, driven by increasing demand in the pharmaceutical and healthcare sectors for efficient, flexible, and cost-effective solutions for liquid handling in bioprocessing applications. These pumps are integral in various stages of biopharmaceutical production, including cell culture, media preparation, and product recovery. The adoption of single-use technology in biomanufacturing processes is a key driver of market expansion, offering significant advantages such as reduced risk of contamination, lower operational costs, and enhanced product quality.

Market Size

The Single-use Bioprocessing Pumps market is poised for steady growth, with a compound annual growth rate (CAGR) forecasted between 7% and 9% during the forecast period. The ongoing shift towards single-use systems in pharmaceutical manufacturing is expected to fuel market demand, particularly as the biopharmaceutical industry continues to expand. The integration of single-use pumps in various applications across healthcare and life sciences is anticipated to further accelerate market growth.

Market Share & Trends Analysis

By Application

The market is segmented by application, with pharmaceutical companies, hospitals, and clinics accounting for the majority of market demand.

• Pharmaceutical Companies: Pharmaceutical companies are the largest consumers of single-use bioprocessing pumps, with this segment estimated to account for 50% to 55% of the market share. The growing demand for biologics and biosimilars is driving this segment's growth, as these companies increasingly rely on single-use technologies for production scalability, process efficiency, and cost reduction. This segment is expected to grow at a CAGR of 8% to 10%.
• Hospitals: Hospitals are also increasingly adopting single-use bioprocessing pumps, primarily for applications in drug administration, IV therapy, and other clinical procedures. The market share for this segment is estimated to be between 25% and 30%, with a growth rate of 6% to 8% CAGR as hospitals integrate more advanced bioprocessing equipment to enhance patient care and improve operational efficiency.
• Clinics: The clinic segment, while smaller, is growing steadily as more clinics adopt bioprocessing solutions for specialized treatments and patient care. This segment is projected to grow at a CAGR of 5% to 7%, with a market share of approximately 15% to 20%.

By Product Type

Single-use bioprocessing pumps are available in various configurations, with key product types including single-use diaphragm pumps, single-use low shear pumps, and others.

• Single-Use Diaphragm Pump: Single-use diaphragm pumps are among the most widely used pumps in bioprocessing due to their excellent performance in aseptic environments and ability to handle various liquid viscosities. This product type is expected to dominate the market, with a CAGR of 7% to 9%, driven by their versatility and application across different phases of bioprocessing.
• Single-Use Low Shear Pump: The single-use low shear pump segment is growing in popularity due to its suitability for sensitive biological fluids and cell culture applications. This segment is forecasted to grow at a CAGR of 8% to 10%, driven by increasing demand in the pharmaceutical and biotech industries, particularly in applications requiring gentle fluid handling.
• Others: Other types of single-use pumps, such as peristaltic and piston pumps, are also experiencing steady growth, though they represent a smaller portion of the market. This segment is expected to grow at a CAGR of 5% to 7%, catering to niche applications where specific pumping characteristics are required.

By Key Players

The Single-use Bioprocessing Pumps market is highly competitive, with several key players contributing to the development of innovative products and solutions.

• Dover Corporation: Dover Corporation is a leading provider of fluid handling solutions, offering a range of single-use pumps designed to meet the stringent requirements of the biopharmaceutical industry.
• Avantor: Avantor is a major player in the bioprocessing market, supplying single-use pumps and other bioprocessing equipment used in pharmaceutical manufacturing.
• Levitronix: Levitronix specializes in providing precision pumps and liquid handling solutions, including single-use bioprocessing pumps for sensitive fluid transfer applications.
• Pumpcell: Pumpcell offers high-quality, single-use pumps that are designed for efficient, contamination-free operation in biopharmaceutical manufacturing processes.
• Promecon: Promecon develops innovative pump solutions, including single-use pumps for bioprocessing applications, focusing on efficiency and operational reliability.

By Region

The market for Single-use Bioprocessing Pumps is geographically diverse, with significant growth anticipated across North America, Europe, and the Asia-Pacific region.

• North America: North America is expected to maintain a dominant market share of 35% to 40%, with a projected CAGR of 8% to 10%. The region’s strong pharmaceutical industry, combined with advancements in biomanufacturing technologies, drives this growth.
• Europe: Europe is anticipated to capture a market share of 25% to 30%, with a CAGR of 7% to 9%. The adoption of single-use systems in the biopharmaceutical sector and healthcare industry is contributing to the region’s growth.
• Asia-Pacific: The Asia-Pacific region is projected to experience the highest growth rate, with a CAGR of 9% to 11%. Rapid advancements in pharmaceutical manufacturing, increasing healthcare investments, and growing demand for bioprocessing solutions are key drivers in this region. The market share in this region is estimated at 20% to 25%.
• Rest of the World: Other regions, including Latin America and the Middle East, are expected to see moderate growth, with a CAGR of 5% to 7%, driven by expanding healthcare infrastructure and biopharmaceutical sectors.

Segment Forecasts (2025-2030)

Growth in Key Segments

• Pharmaceutical Companies: The pharmaceutical segment will continue to dominate, growing at a rate of 8% to 10% CAGR due to the increasing demand for biologics, biosimilars, and personalized medicine.
• Hospitals: The hospital segment will see growth at a CAGR of 6% to 8%, driven by innovations in healthcare technologies and the adoption of single-use bioprocessing systems for drug administration and clinical treatments.
• Clinics: Clinics will experience steady growth, with a CAGR of 5% to 7%, as they increasingly incorporate bioprocessing pumps in specialized treatments.